(Q36269469)

13 August 2017

Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction (English)

1 reference

13 August 2017

1 reference

G E Fiszbajn

1

1 reference

13 August 2017

R G Lipowicz

2

1 reference

13 August 2017

L Elberger

3

1 reference

13 August 2017

A Grabia

4

1 reference

13 August 2017

S D Papier

5

1 reference

13 August 2017

S P Brugo Olmedo

6

1 reference

13 August 2017

C F Chillik

7

1 reference

13 August 2017

1 May 2000

1 reference

Journal of Assisted Reproduction and Genetics

13 August 2017

1 reference

13 August 2017

17

1 reference

13 August 2017

5

1 reference

13 August 2017

260-263

1 reference

Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonists

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Follicle cyst formation following long-acting gonadotropin-releasing hormone analog administration

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Ovarian cyst aspiration and the outcome of in vitro fertilization.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

The development of functional ovarian cysts during pituitary down-regulation.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455200

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10976412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ovarian cyst formation during the use of a GnRH analogue in an IVF programme

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10976412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Follicle cysts after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10976412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1023/A:1009406315729

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference

13 August 2017

PubMed publication ID

10976412

1 reference